HDL Subclasses and the Distribution of Paraoxonase-1 Activity in Patients with ST-Segment Elevation Acute Myocardial Infarction
暂无分享,去创建一个
A. Neskovic | M. Zdravković | N. Bogavac-Stanojević | J. Kotur-Stevuljević | J. Vekić | M. Mihajlović | S. Hinic | S. Kafedžić | M. Cerović | M. Stefanović | A. Zeljković | I. Ilic | Saska Djekic
[1] J. Kotur-Stevuljević,et al. Overweight and obesity in polycystic ovary syndrome: association with inflammation, oxidative stress and dyslipidaemia , 2021, British Journal of Nutrition.
[2] J. Linseisen,et al. Association between inflammatory markers and serum paraoxonase and arylesterase activities in the general population: a cross-sectional study , 2021, Lipids in Health and Disease.
[3] A. Stefanović,et al. Investigation of IgG anti-oxLDL antibody levels and HDL and LDL subclasses in patients with ST-segment elevation acute myocardial infarction , 2021 .
[4] L. Cupples,et al. Small Dense Low‐Density Lipoprotein Cholesterol Is the Most Atherogenic Lipoprotein Parameter in the Prospective Framingham Offspring Study , 2021, Journal of the American Heart Association.
[5] N. Wong,et al. The Evolving Understanding and Approach to Residual Cardiovascular Risk Management , 2020, Frontiers in Cardiovascular Medicine.
[6] K. Kotani,et al. Paraoxonase 1, HDL Subclasses and Post Surgery Acute Inflammation: A Pilot Study , 2019, Antioxidants.
[7] M. Najafi,et al. The effects of oxidative stress on the development of atherosclerosis , 2019, Biological chemistry.
[8] A. Stefanović,et al. Activity of paraoxonase 1 (PON1) on HDL2 and HDL3 subclasses in renal disease. , 2018, Clinical biochemistry.
[9] P. Libby,et al. Atherosclerosis and inflammation: overview and updates. , 2018, Clinical science.
[10] G. Norata,et al. The Interplay of Lipids, Lipoproteins, and Immunity in Atherosclerosis , 2018, Current Atherosclerosis Reports.
[11] P. Portincasa,et al. Cholesterol and Lipoprotein Metabolism and Atherosclerosis: Recent Advances In reverse Cholesterol Transport. , 2017, Annals of hepatology.
[12] X. Liao,et al. Determination of risk factors affecting the in-hospital prognosis of patients with acute ST segment elevation myocardial infarction after percutaneous coronary intervention , 2017, BMC Cardiovascular Disorders.
[13] A. Kontush,et al. Antioxidative activity of high-density lipoprotein (HDL): Mechanistic insights into potential clinical benefit , 2017, BBA clinical.
[14] M. Simionescu,et al. Dysfunctional high-density lipoproteins have distinct composition, diminished anti-inflammatory potential and discriminate acute coronary syndrome from stable coronary artery disease patients , 2017, Scientific Reports.
[15] E. Grapsa,et al. Association of lipid profile with serum PON1 concentration in patients with chronic kidney disease , 2016, Renal failure.
[16] A. Kontush,et al. HDL particle subpopulations: Focus on biological function , 2015, BioFactors.
[17] A. Gugliucci,et al. Paraoxonase 1 and HDL maturation. , 2015, Clinica chimica acta; international journal of clinical chemistry.
[18] A. Gugliucci. Activation of paraoxonase 1 is associated with HDL remodeling ex vivo. , 2014, Clinica chimica acta; international journal of clinical chemistry.
[19] P. Barter,et al. Cardioprotective functions of HDLs1 , 2014, Journal of Lipid Research.
[20] G. Rossi,et al. The Role of Oxidized Low-Density Lipoproteins in Atherosclerosis: The Myths and the Facts , 2013, Mediators of inflammation.
[21] K. Kotani,et al. Enzymatic assessment of paraoxonase 1 activity on HDL subclasses: a practical zymogram method to assess HDL function. , 2013, Clinica chimica acta; international journal of clinical chemistry.
[22] M. Banach,et al. Dysfunctional HDL: a novel important diagnostic and therapeutic target in cardiovascular disease? , 2012, Progress in lipid research.
[23] A. Kontush,et al. Biological activities of HDL subpopulations and their relevance to cardiovascular disease. , 2011, Trends in molecular medicine.
[24] N. Bogavac-Stanojević,et al. LDL and HDL subclasses in acute ischemic stroke: prediction of risk and short-term mortality. , 2010, Atherosclerosis.
[25] H. Nakazawa,et al. Validation of the Friedewald Equation for Evaluation of Plasma LDL-Cholesterol , 2007, Journal of clinical biochemistry and nutrition.
[26] Z. Jelić-Ivanović,et al. LDL and HDL subclasses and their relationship with Framingham risk score in middle-aged Serbian population. , 2007, Clinical biochemistry.
[27] B. Hansel,et al. Defective antioxidative activity of small dense HDL3 particles in type 2 diabetes: relationship to elevated oxidative stress and hyperglycaemia , 2005, Diabetologia.
[28] D. Rainwater,et al. Improved method for making nondenaturing composite gradient gels for the electrophoretic separation of lipoproteins Published, JLR Papers in Press, January 16, 2004. DOI 10.1194/jlr.D300035-JLR200 , 2004, Journal of Lipid Research.
[29] A. Kontush,et al. Small, Dense HDL Particles Exert Potent Protection of Atherogenic LDL Against Oxidative Stress , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[30] R. Rosenson,et al. Myocardial injury: the acute phase response and lipoprotein metabolism. , 1993, Journal of the American College of Cardiology.
[31] R. Krauss,et al. Composition and distribution of low density lipoprotein fractions in hyperapobetalipoproteinemia, normolipidemia, and familial hypercholesterolemia. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[32] A. Orekhov,et al. Paraoxonase and atherosclerosis-related cardiovascular diseases. , 2017, Biochimie.
[33] T. Ichida,et al. World Medical Association declaration of Helsinki , 2008, Gastroenterologia Japonica.
[34] E. Falk,et al. Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. , 2003, European heart journal.
[35] B. McLellan,et al. Early measurement of systemic lipid peroxidation products in the plasma of major blunt trauma patients. , 1991, The Journal of trauma.